Finally! A model for progesterone receptor action in normal human breast

Endocrinology

Volumn 150, Issue 7, 2009, Pages 2988-2990

  Lydon, John P ^a   Edwards, Dean P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; GROWTH FACTOR; PROGESTERONE RECEPTOR; PROLACTIN;

BASEMENT MEMBRANE; BREAST; BREAST BIOPSY; BREAST CELL; BREAST EPITHELIUM; CELL CULTURE; CELL CYCLE; CELL FATE; CELL MEMBRANE; CENTROMERE; HUMAN; IMMUNOHISTOCHEMISTRY; MINICHROMOSOME; MODEL; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BREAST; FEMALE; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, PROGESTERONE;

EID: 67649646764     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0383     Document Type: Review

References (38)

1. Pike MC, Spicer DV, Dahmoush L, Press MF 1993 Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15: 17-35 (Pubitemid 23269068)
2. Fernandez-Valdivia R, Mukherjee A, Mulac-Jericevic B, Conneely OM, DeMayo FJ, Amato P, Lydon JP 2005 Revealing progesterone's role in uterine and mammary gland biology: insights from the mouse. Semin Reprod Med 23:22-37 (Pubitemid 40333584)
3. Anderson E 2002 The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res 4:197-201 (Pubitemid 34918998)
4. Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ 1999 Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 84:4559-4565 (Pubitemid 30677676)
5. Beral V 2003 Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427 (Pubitemid 36999703)
6. Lee S, Kolonel L, Wilkens L, Wan P, Henderson B, Pike M 2006 Postmenopausal hormone therapy and breast cancer risk: the multiethnic cohort. Int J Cancer 118:1285-1291 (Pubitemid 43185619)
7. RossouwJE, Anderson GL, Prentice RL, LaCroixAZ,Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333 (Pubitemid 34761611)
8. Ross RK, Paganini-Hill A, Wan PC, PikeMC2000 Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92:328-332 (Pubitemid 30117736)
9. Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ 2006 Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol 24:e49-e50
10. Bast Jr RC, Ravdin P, Hayes DF, Bates S, Fritsche Jr H, Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR 2001 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1865-1878 (Pubitemid 32230890)
11. Creighton CJ, Kent Osborne C, van de Vijver MJ, Foekens JA, Klijn JG, Horlings HM, Nuyten D, Wang Y, Zhang Y, Chamness GC, Hilsenbeck SG, Lee AV, Schiff R 2009 Molecular profiles of progesterone receptor loss in human breast tumors. Breast Cancer Res Treat 114:287-299
12. Cui X, Schiff R, Arpino G, Osborne CK, LeeAV 2005 Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol 23:7721-7735
13. Sutherland RL, Prall OW, Watts CK, Musgrove EA 1998 Estrogen and progestin regulation of cell cycle progression. J Mamm Gland Biol Neoplasia 3:63-72 (Pubitemid 128513220)
14. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery Jr CA, Shyamala G, Conneely OM, O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9:2266-2278
15. Fernandez-Valdivia R, Mukherjee A, Creighton CJ, Buser AC, DeMayo FJ, Edwards DP, Lydon JP 2008 Transcriptional response of the murinemammary gland to acute progesterone exposure. Endocrinology 149:6236-6250
16. Chatterton Jr RT, Lydon JP, Mehta RG, Mateo ET, Pletz A, Jordan VC 2002 Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro. Cancer Lett 188:47-52 (Pubitemid 35292328)
17. Lydon JP, Ge G, Kittrell FS, Medina D, O'MalleyBW1999 Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res 59:4276-4284 (Pubitemid 29418743)
18. Carnevale RP, Proietti CJ, Salatino M, Urtreger A, Peluffo G, Edwards DP, Boonyaratanakornkit V, CharreauEH,Bal de Kier Joffé E, Schillaci R, Elizalde PV 2007 Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. Mol Endocrinol 21:1335-1358
19. Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon J 2003 Hormone dependence in premalignant mammary progression. Cancer Res 63:1067-1072 (Pubitemid 36278440)
20. Poole AJ, Li Y, Kim Y, Lin SC, Lee WH, Lee EY 2006 Prevention of Brca1- mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 314:1467-1470 (Pubitemid 44871955)
21. Graham J, Mote P, Salagame U, van Dijk J, Balleine R, Huschtscha L, Reddel RR, Clarke C 2009 DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 150:3318-3326
22. Novaro V, Roskelley CD, Bissell MJ 2003 Collagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells. J Cell Sci 116:2975-2986 (Pubitemid 36926986)
23. Debnath J, Brugge JS 2005 Modelling glandular epithelial cancers in threedimensional cultures. Nat Rev 5:675-688 (Pubitemid 41486361)
24. Clarke RB, Howell A, Potten CS, Anderson E 1997 Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57:4987-4991 (Pubitemid 27498105)
25. Rosen JM 2003 Hormone receptor patterning plays a critical role in normal lobuloalveolar development and breast cancer progression. Breast Dis 18:3-9 (Pubitemid 39193327)
26. Russo J, Ao X, Grill C, Russo IH 1999 Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 53:217-227 (Pubitemid 29209891)
27. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA 2000 Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 14:650-654 (Pubitemid 30176819)
28. Das SK, Chakraborty I, Paria BC, Wang XN, Plowman G, Dey SK 1995 Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus. Mol Endocrinol 9:691-705
29. Fernandez-Valdivia R, Mukherjee A, Ying Y, Li J, Paquet M, Demayo FJ, Lydon JP, The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev Biol 328:127-139
30. LaMarca HL, Rosen JM 2008 Minireview: hormones and mammary cell fate-what will I become when I grow up? Endocrinology 149:4317-4321
31. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS 2004 Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 6:R605-R615
32. Korkaya H, Wicha MS 2009 HER-2, Notch, and breast cancer stem cells: targeting an axis of evil. Clin Cancer Res 15:1845-1847
33. Hopp TA, Weiss HL, Hilsenbeck SG, Cui Y, Allred DC, Horwitz KB, Fuqua SA 2004 Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates. Clin Cancer Res 10:2751-2760 (Pubitemid 38509151)
34. Mote PA, Bartow S, Tran N, Clarke CL 2002 Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 72:163-172 (Pubitemid 34407211)
35. Buser AC, Gass-Handel EK, Wyszomierski SL, Doppler W, Leonhardt SA, Schaack J, Rosen JM, Watkin H, Anderson SM, Edwards DP 2007 Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the β-casein gene in mammary epithelial cells. Mol Endocrinol 21:106-125 (Pubitemid 46043298)
36. Oakes SR, Rogers RL, Naylor MJ, Ormandy CJ 2008 Prolactin regulation of mammary gland development. J Mamm Gland Biol Neoplasia 13:13-28
37. Boonyaratanakornkit V, McGowan E, Sherman L, Mancini MA, Cheskis BJ, Edwards DP 2007 The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol 21:359-375 (Pubitemid 46184890)
38. Faivre EJ, Daniel AR, Hillard CJ, Lange CA 2008 Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Mol Endocrinol 22:823-837